Advisory Panel Urges FDA To Down-classify Certain Tuberculosis Tests
This article was originally published in The Gray Sheet
Executive Summary
FDA's Microbiology Devices advisory panel recommended that the agency down-classify certain advanced tests for tuberculosis infection during a June 29 meeting.